Influenza

Findings of JAMA Network Open analysis reveal effects of interventions designed to prevent spread.

This flu season, the CDC reported at least 2.4 million flu illnesses, 23,000 hospitalizations, and 1,400 deaths from flu so far.

A recent study in Australia highlights the risk of severe influenza disease in infants younger than 6 months and the need for preventative measures to protect this vulnerable population.

Key signs and symptoms to help distinguish between the 2 respiratory illnesses.

A team of researchers sought to study the epidemiological characteristics of RSV in pediatric influenza-like illness cases.

A new study sought to address the association between a usual source of care and influenza vaccination rates among pregnant women.

No influenza-related hospitalizations of children were found in a nationwide study of the impact of the COVID-19 pandemic on the 20/21 flu season.

A pregnant woman is reported to be the country’s first person to be infected simultaneously with COVID-19 and influenza.

Clinical and public health laboratories reported increased influenza virus detections over the past few weeks, but US cases remains comparatively low to previous flu seasons.

Individuals from European backgrounds had higher type 1 interferon pathway activity during early influenza infection than individuals with African genetic heritage.

Analysis documents 9% rise in shots distributed after federal officials pushed for vaccination.

The FDA has approved patients 6 months and older to receive Seqirus's first-ever adjuvanted, cell-based influenza vaccine.

The National Academy of Medicine released 4 reports with COVID-19-influenced recommendations to prepare and respond to an influenza pandemic.

The CDC’s Advisory Committee on Immunization Practices voted to recommend hepatitis B, orthopoxviruses, and Ebola vaccines to certain populations, as well as approving 2022 immunization schedules for children, adolescents, and adults.

The National Foundation for Infectious Diseases (NFID) recently sponsored a media briefing addressing the risks of contracting influenza and pneumococcal disease in the midst of a still-flourishing COVID-19 pandemic.

New survey finds little more than half of US adults are planning to obtain vaccination against influenza despite urging by health officials.

New clinical trial is first to describe concomitant administration of any vaccine with either an adenoviral vector or mRNA COVID-19 vaccine.

The broad host range and natural reassortment of the influenza virus has played an instrumental role in previous pandemics, and the virus is poised for future large-scale outbreaks.

With the Delta cases surging in recent weeks, and the upcoming flu season almost upon us, here is a glimpse of what providers and the public can expect when both viruses are circulating.

Here are some insights into this upcoming 2021-2022 influenza season as well as concerns of the twindemic and addressing both the seasonal and pandemic viruses simultaneously.

Past research has observed links between cardiovascular disease and influenza infection. Vaccination may benefit at-risk patients.

Final thoughts from experts on controlling COVID-19 and influenza.

Encouraging testing of symptomatic COVID-19 or influenza patients and utilization of available therapeutics.

The concept of the “immunization neighborhood” highlighting the importance of pharmacists in encouraging and administering vaccinations.

The importance of a rapid and accurate COVID-19 and influenza test.